Supriya Lifescience Limited (NSE:SUPRIYA)
India · Delayed Price · Currency is INR 604.80
+23.95 (4.12%)
Mar 10, 2026, 3:30 PM IST
Supriya Lifescience Market Cap
Supriya Lifescience has a market cap or net worth of 48.68 billion as of March 10, 2026. Its market cap has decreased by -9.29% in one year.
Market Cap
48.68B
Enterprise Value
47.70B
Revenue
7.35B
Ranking
n/a
PE Ratio
26.25
Stock Price
604.80
Market Cap Chart
Since December 28, 2021, Supriya Lifescience's market cap has increased from 31.46B to 48.68B, an increase of 54.74%. That is a compound annual growth rate of 10.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 46.75B | -22.71% |
| Dec 31, 2025 | 60.48B | 1.58% |
| Dec 31, 2024 | 59.54B | 135.04% |
| Dec 29, 2023 | 25.33B | 33.91% |
| Dec 30, 2022 | 18.92B | -51.41% |
| Dec 31, 2021 | 38.93B | 23.76% |
| Dec 28, 2021 | 31.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 630.68B |
| Anthem Biosciences | 370.75B |
| OneSource Specialty Pharma | 173.64B |
| Concord Biotech | 122.96B |
| Blue Jet Healthcare | 65.15B |
| Zota Health Care | 39.75B |
| Dishman Carbogen Amcis | 24.81B |
| Panacea Biotec | 20.45B |